!!
#Fluoroquinolone Antibiotics: Safety Communication - Increased Risk of Ruptures or Tears in the #Aorta Blood Vessel in Certain Patients
https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm628960.htm
RECOMMENDATION:
Healthcare professionals should:
Avoid prescribing fluoroquinolone antibiotics to patients who have an aortic aneurysm or are at risk for an aortic aneurysm, such as patients with peripheral atherosclerotic vascular diseases, hypertension, certain genetic conditions such as Marfan syndrome and Ehlers-Danlos syndrome, and elderly patients.
Prescribe fluoroquinolones to these patients only when no other treatment options are available.
Advise all patients to seek immediate medical treatment for any symptoms associated with aortic aneurysm.
Stop fluoroquinolone treatment immediately if a patient reports side effects suggestive of aortic aneurysm or dissection.
#Fluoroquinolone Antibiotics: Safety Communication - Increased Risk of Ruptures or Tears in the #Aorta Blood Vessel in Certain Patients
https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm628960.htm
RECOMMENDATION:
Healthcare professionals should:
Avoid prescribing fluoroquinolone antibiotics to patients who have an aortic aneurysm or are at risk for an aortic aneurysm, such as patients with peripheral atherosclerotic vascular diseases, hypertension, certain genetic conditions such as Marfan syndrome and Ehlers-Danlos syndrome, and elderly patients.
Prescribe fluoroquinolones to these patients only when no other treatment options are available.
Advise all patients to seek immediate medical treatment for any symptoms associated with aortic aneurysm.
Stop fluoroquinolone treatment immediately if a patient reports side effects suggestive of aortic aneurysm or dissection.